REUTERS - Human Genome Sciences Inc
The deal is expected to be announced before the U.S. stock market opens on Monday, the sources added.
The price represents an increase to Glaxo's previous offer of $13 a share.
Human Genome shares ended trading on Friday at $13.58.
(Reporting by Greg Roumeliotis in New York)